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c h a p t e r  7
Estimation of the prevalence 
and rate of acute transfusion reactions
















In sub-Saharan Africa, acute transfusion reactions are likely common but transfusion reaction 
surveillance systems have not been widely established. In 2008, The Blood Transfusion Ser-
vice of Namibia implemented a national acute transfusion reaction surveillance system, but 
substantial under-reporting was suspected. We estimated the actual prevalence and rate of 
acute transfusion reactions occurring in Windhoek, Namibia.
Methods
The percentage of transfusion events resulting in a reported acute transfusion reaction was 
calculated. Actual percentage and rates of acute transfusion reactions per 1,000 transfused 
units were estimated by reviewing patient records from six hospitals, which transfuse >99% 
of all blood in Windhoek. Patient records for 1,162 transfusion events occurring between Jan-
uary 1–December 31 2011 were randomly selected. Clinical and demographic information were 
abstracted and Centers for Disease Control and Prevention National Healthcare Safety Net-
work criteria were applied to categorize acute transfusion reactions. [1]
Results
From January 1-December 31, 2011, 3,697 transfusion events occurred (involving 10,338 blood 
units) in the selected hospitals. Eight (0.2%) acute transfusion reactions were reported to the 
surveillance system. Of the 1,162 transfusion events selected, medical records for 785 transfu-
sion events were analyzed, and 28 acute transfusion reactions were detected, of which only 
one was also reported to the surveillance system. An estimated 3.4% (95% confidence inter-
val [CI]: 2.3-4.4) of transfusion events occurring in Windhoek resulted in an acute transfusion 
reaction, with an estimated rate of 11.5 (95%CI: 7.6-14.5) acute transfusion reactions per 1,000 
transfused units. 
Conclusion
The estimated actual rate of acute transfusion reactions is higher than the rate reported to 
the national hemovigilance system. Improved surveillance and interventions to reduce trans-
fusion-related morbidity and mortality are required in Namibia.
7.2 Introduction
Since the 1980’s, programs and policies related to blood transfusion safety in sub-Saharan 
Africa have focused on reducing the risk of transfusion-transmitted HIV infection. [2-4] While 
much has been done to quantify the risk of HIV transmission through blood transfusion [5-9] 
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and to identify risk-reduction strategies, [10-14] there is limited information related to other 
adverse transfusion outcomes in sub-Saharan Africa, including acute transfusion reactions 
such as sepsis due to bacterial contamination of the donor unit and hemolysis secondary to 
transfusion with ABO incompatible blood products. However, based on data from industrial-
ized countries, [15-18] previously published reports describing unsafe transfusion practices, [5, 
19-21] and some limited studies from the region that have evaluated adverse transfusion-re-
lated outcomes, [22, 23] acute transfusion reactions in sub-Saharan Africa are likely more com-
mon than they are clinically recognized.
 Surveillance systems designed to monitor and detect serious transfusion reactions are 
now in place for most industrialized countries as part of national hemovigilance systems, 
although the methodology and extent of implementation differ. [15,16,24] With the excep-
tion of South Africa, such systems have historically been absent in sub-Saharan Africa. [25] 
In Namibia, a country of 2.1 million people in south-western Africa, The Blood Transfusion 
Service of Namibia (NAMBTS) is the only organization authorized to collect, process, and dis-
tribute blood and blood components intended for transfusion. From 2000-2007, suspected 
transfusion reactions in the country were reported to NAMBTS using a non-standardized pro-
cess which did not include clinical investigation or a comprehensive laboratory follow-up for 
reported events. As a result, reporting clinicians received limited feedback from the blood 
service and the system was under-utilized. In 2008, NAMBTS implemented a national hemov-
igilance system which included a systematic method of reporting, along with comprehensive 
clinical and laboratory investigations of all reported acute transfusion reactions in the coun-
try. This system is intended to provide timely, comprehensive feedback to support the imple-
mentation of corrective measures to reduce transfusion-associated morbidity and mortality. 
In 2010, NAMBTS conducted a national audit of transfusion practices in all 46 transfusion 
facilities and found a lack of standardized transfusion practice between facilities and health 
care practitioners (personal communication: B. Lohrke 25 July 2012). Using the results of the 
audit, NAMBTS revised its training curriculum and launched the “BeST: Better and Safer Trans-
fusions” training program based on an Australian model. [26] The NAMBTS “BeST” program is 
designed to strengthen training related to clinical transfusion practices, patient monitoring, 
and reporting of acute transfusion reactions. Under the revised reporting process, all health-
care workers who order or perform transfusions are asked to voluntarily report all acute 
transfusion reactions to NAMBTS. As a first step, the blood bank technologist and the on-
call NAMBTS medical officer are notified via telephone by the reporting facility. The medical 
officer provides clinical guidance and specific instructions related to sample collection. This 
phone call is followed by submission of a standard, paper-based transfusion reaction report, 
along with patient samples and the remaining unused contents of the blood unit to NAMBTS 
via courier.
 Between 2000-2007, reports of acute transfusion reactions increased from three to 10 
per year (personal communication B. Lohrke 25 July 2012). Following the launch of the nation-
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al hemovigilance system in 2008, the number of reports continued to increase, but despite 
comprehensive training and outreach activities, only 20 reactions (0.1%) were reported out of 
approximately 20,000 units transfused nationally in 2010. Few published studies have esti-
mated the prevalence or rate of acute transfusion reactions in sub-Saharan Africa. [22,27,28] 
But this likely represents under-recognition and reporting as acute transfusion reactions have 
been reported to occur in approximately 1-3% of all transfusions in other countries. [29] In 
order to enhance monitoring of blood transfusions, facilitate the implementation of correc-
tive measures to protect transfusion recipients, and reduce the future occurrence of adverse 
events, quantifying the burden of acute transfusion reactions and determining the associated 
morbidity and mortality are important objectives for blood services in the region. This study 
was conducted to estimate the prevalence and rate of acute transfusion reactions occurring 
in Windhoek, Namibia, and by using retrospective medical record review, to compare the esti-
mated prevalence of adverse events with the prevalence reported to the NAMBTS hemovigi-
lance system. The probable diagnoses and severity of acute transfusion reactions occurring in 
Windhoek are also described.
7.3 Materials and Methods
Approvals and informed consent
All data collection followed approval from the Namibia Ministry of Health and Social Services 
(MOHSS). Because the study involved the evaluation of a routine surveillance program, it was 
considered exempt from review by an Institutional Review Board by the office of the Associ-
ate Director for Science of the U.S. Centers for Disease Control and Prevention (CDC), Division 
of Global HIV/AIDS in Atlanta, Georgia.
Study sites and design
Due to logistical and resource constraints, the study was limited to six transfusion facilities in 
Windhoek, the capital of Namibia. These facilities collectively transfuse >99% of all blood in 
Windhoek. In 2010, 8,580 (36%) of the 23,744 blood units transfused in Namibia were trans-
fused in the six selected facilities. Except in rare cases where whole blood may be clinically 
indicated (e.g., neonatal exchange transfusion), all transfusions in Namibia are conducted us-
ing blood components. Since most patients are transfused more than one unit of blood in a 
24 hour period, for the present study, “transfusion events,” rather than individual units, were 
reviewed in the medical record for evidence of an acute transfusion reaction. A transfusion 
event was defined as a single episode encompassing the duration of transfusion and the 24 
hour period following cessation of transfusion in which a patient received any combination of 
components and/or number of units for one clinical indication.
Calculation of prevalence of acute transfusion reactions as reported to the surveillance system
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To determine the percentage of transfusion events resulting in acute transfusion reactions 
that were reported to the surveillance system, case reports submitted to NAMBTS by the six 
selected Windhoek facilities between January 1, 2011 and December 31, 2011 were reviewed. 
These documents contained clinical, laboratory, and radiographic data, and results of the 
NAMBTS investigation. The likely diagnosis determined by the NAMBTS investigators was 
recorded for each report. The denominator for the calculation of the percentage of reported 
transfusion events resulting in acute transfusion reactions was the total number of transfu-
sion events occurring in the six selected Windhoek hospitals in 2011.
Estimation of the percentage and rate of acute transfusion reactions
Given the suspected under-reporting of adverse transfusion events, we estimated an actual 
percentage and rate of acute transfusion reactions occurring in the Windhoek facilities. This 
estimated percentage was based on a review of patient records and compared with the per-
centage reported to the surveillance system. Determination of the sample size of medical 
records needed for review for the Windhoek study sites was based on a published estimated 
acute transfusion reaction rate of 1%. [29] A sample size of 1,162 was selected for this study as 
it would produce a two-sided 95% exact confidence interval (95% CI) with a total width of 1% 
when the detected percentage is 1%. [30] The observed sample size of 785 would have yielded 
a 95% CI with a total width of 1.5% for an estimated acute transfusion reaction rate of 1%. A 
roster of patient medical records representing 1,162 randomly selected transfusion events was 
generated through a SQL query of the electronic NAMBTS database. Transfusion events were 
eligible if they occurred between January 1 and December 31, 2011, and if specific identifier 
information (e.g., patient name, date of transfusion) was available to facilitate location of the 
medical record in the facilities. The selected transfusion events were intended to be represen-
tative of Windhoek for the specified timeframe.
Data collection
Patient records were retrospectively evaluated during February-April 2012 for evidence of an 
acute transfusion reaction occurring during or within 24 hours of the final unit in the trans-
fusion event. Data collection from the medical record abstraction was performed using the 
Census and Survey Processing System (CSPro) (U.S. Census Bureau, Washington, DC). Patient 
demographic information, physician and/or nurse documentation, laboratory data, and ra-
diographic findings were reviewed for each medical record. Pertinent demographic and clin-
ical information related to each transfusion event were entered into the CSPro tool which 
was programmed to assign a likely acute transfusion reaction diagnosis, severity score, and 
imputability score for each transfusion event. Imputability is defined as the likelihood that 
the reaction was associated with the transfusion event. [1] These scores were based on criteria 
described in the CDC National Healthcare Safety Network Hemovigilance Module (NHSN). 
[1] If the physician’s or nurse’s documentation, laboratory, or radiographic findings did not 
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suggest an acute transfusion reaction, the CSPro program assigned a diagnosis of ‘none.’ For 
transfusion events assigned to the ‘none’ category, severity and imputability scores were not 
calculated.
 If the documentation in the medical record suggested an acute transfusion reaction had 
occurred, a diagnosis, based on NHSN criteria, [1] was generated by the pre-programmed CS-
Pro algorithm. Diagnoses included: allergic, acute hemolytic, febrile non-hemolytic, hypoten-
sive, sepsis due to bacterial contamination of the donor unit, transfusion associated circula-
tory overload, transfusion associated dyspnea, and transfusion-related acute lung injury. [1] If 
documentation indicated that an acute transfusion reaction had occurred, but sufficient data 
were not available for the algorithm to assign a specific diagnosis, a designation of “transfu-
sion reaction, not otherwise specified” was assigned. Based on available documentation for 
each transfusion event for which an acute transfusion reaction had occurred, severity scores 
were calculated as mild, moderate, life-threatening, or death. Imputability scores were desig-
nated as: possible, probable, or definite. Only two investigators (S.V. Basavaraju and B. Lohrke) 
could override the CSPro algorithms and assign new diagnoses, severity, or imputability 
scores. All acute transfusion reactions detected through the review of patient medical records 
were further evaluated to determine if they were previously reported by hospital staff to 
the surveillance system. All acute transfusion reactions detected through the record review, 
which were either designated as life threatening or death, were subsequently referred for 
investigation by NAMBTS. The results of subsequent investigations are not presented here.
Statistical analysis
The percentages of transfusion events resulting in an acute transfusion reaction as reported 
to the surveillance system, and as determined by the chart abstraction, were calculated and 
compared using a one proportion Z-test. The percentages of transfusion events resulting in a 
reported or an unreported acute transfusion reaction was estimated using the total sampled 
transfusion events as the denominator. The reported rate of acute transfusion reactions per 
1,000 units was calculated using the total units transfused during 2011 at the selected facil-
ities as the denominator. The estimated rate of acute transfusion reactions per 1,000 units 
was calculated using data collected from the medical record abstraction. 
 Estimated rates of acute transfusion reactions per 1,000 units of each component type 
were also calculated using data collected from the medical record abstraction. For these 
estimates, a fraction of each acute transfusion reaction detected in the study sample was 
attributed to each component in proportion to the number of component units transfused 
during the respective transfusion event (e.g., 0.75 acute transfusion reactions were attributed 
to packed red blood cells (PRBC) if three PRBC units and one platelet unit were transfused 
during the transfusion event). Relative standard error (RSE) was calculated for rates of acute 
transfusion reactions for each component type. The estimated percentage and rates were 
weighted to account for variation in non-response between facilities. The weight adjustments 
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were defined as [1/total response rate] at each facility. Application of sample weights allowed 
for adjustment of prevalence and rate estimates to reduce bias resulting from non-response. 
Confidence intervals were adjusted using a finite population correction factor. [31] All data 
analyses were performed using SAS version 9.2 (SAS Institute Inc., Cary, NC). Weighted analy-
ses were performed using SAS survey procedures.
7.4 Results
Between January 1, 2011 and December 31, 2011, 3,697 transfusion events, which included 
10,373 blood units, (7,777 adult and pediatric PRBC, 1,894 adult and pediatric fresh frozen 
plasma (FFP), 686 adult and pediatric platelets, and 16 whole blood units) occurred in the 
six Windhoek hospitals. NAMBTS received reports of eight acute transfusion reactions from 
these facilities during this period. Of these 3,697 transfusion events, 3,461 (94%) events had 
sufficient patient information in the NAMBTS database to facilitate location of the patient 
medical records (Figure 1). From these 3,461 transfusion events, 1,162 events were selected via 
simple random sampling. Patient medical records for 311 events were either missing or other-
wise inaccessible in the facilities and were excluded. After reviewing the patient medical re-
cords for the remaining 851 transfusion events, 12 transfusion events occurred within 24 hours 
of a second randomly sampled event for the same patient and were collectively analyzed 
as six transfusion events. After reviewing the patient medical records for the remaining 845 
transfusion events, another 58 events were excluded because the medical record contained 
evidence that the transfusion was cancelled or had no documentation that the transfusion 
had occurred. Two transfusion events selected for review occurred during 2010 or 2012 and 
were excluded, leaving 785 transfusion events for data analysis (Figure 1). This total included 
2,284 blood units (1,688 adult and pediatric PRBC, 446 adult and pediatric FFP, 148 adult and 
pediatric platelets, and two whole blood units).
 Four of the eight acute transfusion reactions reported to the surveillance system in 2011 
were mild; two were moderate severity; and one resulted in death (Table 1). 
The severity score for the remaining reported acute transfusion reaction was not document-
ed in the surveillance report. Of the 785 transfusion events documented in patient medical 
records which were retrospectively reviewed, 28 medical records contained evidence that an 
acute transfusion reaction had occurred during or after the associated transfusion event. Of 
the 28 acute transfusion reactions detected through the chart review, only one, an allergic 
reaction, had also been reported to the surveillance system. Twenty of the 28 acute trans-
fusion reactions were classified as mild severity; four were moderate severity; two were life 
threatening; and two resulted in death (Table 2).
148
Table 1: Diagnoses and severity scores of acute transfusion reactions reported to the 
national acute transfusion reaction surveillance system: Windhoek, Namibia - 2011
 Severity     
Diagnosis Mild Moderate Life- Death Not Total
   threatening   Documented
Acute hemolytic - - - - - 0
Allergic 1 1§ - - - 2
Febrile non-hemolytic 3 - - - - 3
Hypotensive - - - 1 - 1
Sepsis due to bacterial  - 1 - - - 1
contamination of the 
donor unit 
Transfusion-associated  - - - - 1 1
circulatory overload 
Transfusion-associated  - - - - - 0
dyspnea 
Transfusion reaction not  - - - - - 0
otherwise specified 
Total 4 2 - 1 1 8 
§ Reaction was also detected by reviewing a selected sample of transfusion events. No cases of transfusion-related 
acute lung injury were reported to the surveillance system or detected reviewing a selected sample of transfusion 
events.
Documentation was not sufficient to assign a specific diagnosis for seven acute transfu-
sion reactions, resulting in a classification of “transfusion reaction not otherwise specified.” 
Based on physician and nursing documentation of clinical signs and symptoms, one of the life 
threatening acute transfusion reactions identified through the medical record review was 
classified by the CSPro algorithm as sepsis due to bacterial contamination of the donor unit. 
One of the two deaths identified through the medical record review was designated by the 
CSPro algorithm as an acute hemolytic reaction. For both of these transfusion events, the 
clinical signs and symptoms were documented while monitoring the patient during and im-
mediately following the transfusion event. 
However, our findings suggest that the clinical staff did not recognize the signs and symptoms 
could have resulted from an acute transfusion reaction and neither of these suspected reac-
tions were reported to the surveillance system. For these events, laboratory data, required by 
NHSN criteria to assign an imputability score of ‘definite’ were not available. However, the 
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Table 2: Diagnoses and severity scores of acute transfusion reactions as determined by 
reviewing a selected sample of transfusion events: Windhoek, Namibia - 2011
  Severity    
Diagnosis Imputability Mild Moderate Life- Death Total
    Threatening
Acute hemolytic      1
 Definite - - - - -
 Probable¶ - - - 1 1
 Possible - - - - -
Allergic      3
 Definite 1 2 - - 3
 Probable - - - - -
 Possible - - - - -
   -
Febrile non-hemolytic  - - - - 10
 Definite 4 - - - 4
 Probable 5 - - - 5
 Possible 1 - - - 1
Hypotensive      1
 Definite - - - - -
 Probable - - - - -
 Possible 1 - - - 1
Sepsis due to bacterial       1
contamination of the donor unit      
 Definite - - - - -
 Probable - - - - -
 Possible¶ - - 1 - 1
Transfusion-associated dyspnea      5
 Definite 1 - - - 1
 Probable 1 - - - 1
 Possible 2 1 - - 3
Transfusion reaction not       7
otherwise specified        
 Definite 1 - - - 1
 Probable 2 1 1 1 5
 Possible 1 - - - 1
Total  20 4 2 2 28
150
clinical details were strongly suggestive of these diagnoses resulting in the imputability des-
ignations of possible (sepsis due to bacterial contamination of the donor unit) and probable 
(acute hemolytic). 
* Laboratory data were unavailable. Clinical scenario, signs, and symptoms were highly consistent with these diag-
noses, resulting in the imputability designations. No cases of transfusion-related acute lung injury were detected 
reviewing a selected sample of transfusion events. The Total column designates the total number of reactions 
detected in each diagnostic category. Imputability scores were based on criteria described in the CDC National 
Healthcare Safety Network Haemovigilance Module and were designated as: Possible, Probable, or Definite. In 
this table, for each diagnosis, only imputability categories for detected acute transfusion reactions are listed in 
the Imputability column. For example, no acute haemolytic reactions with “Possible” or “Definite” imputablity 
designations were detected in this study. Hence, “Possible” and “Definite” are not included in the Imputability 
column for acute haemolytic reactions.
Figure 1: Flow diagram of transfusion events reviewed for evidence of an acute transfusion 
reaction (Windhoek, Namibia, January 1 - December 31, 2011)
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Based on reports received by the surveillance system (eight acute transfusion reactions in 
3,697 transfusion events), the percentage of total transfusion events in Windhoek resulting 
in an acute transfusion reaction was observed to be 0.2% (Table 3). The estimated percentage 
of reported and non-reported acute transfusion reactions calculated from the medical record 
review was 3.4% (95% confidence interval (CI): 2.3-4.4). This estimate was significantly higher 
than the percentage determined by reports to the surveillance system (p< 0.01).
 The rate of acute transfusion reactions per 1,000 blood units transfused was 0.8 when 
calculated using the eight transfusion reactions reported to the surveillance system (10,338 
blood units transfused). This number increased to 11.5 (95% CI: 8.0-15.0) acute transfusion re-
actions per 1,000 blood units transfused when calculated using the number of reactions iden-
tified through the medical chart review. The adjusted estimated rates of acute transfusion 
reactions by component type transfused were: 12.9 (95% CI: 8.7-17.2) per 1,000 adult and pedi-
atric PRBC units; 4.9 (95% CI: 1.4-8.4) per 1,000 adult and pediatric fresh frozen plasma units, 
and; 15.0 (95% CI: 1.0-29.0) per 1,000 adult and pediatric platelet units. No acute transfusion 
reactions were detected for the two whole blood units transfused in the study sample. 
7.5 Discussion
The findings of this study reinforce previously published observations that morbidity and 
mortality related to acute transfusion reactions are a substantial public health problem in 
sub-Saharan Africa. [22] This study found that a significantly greater percentage of transfu-
sion events occurring in Windhoek resulted in an acute transfusion reaction than were re-
ported to the surveillance system in 2011. Four severe transfusion reactions, including two 
deaths, were not reported to the surveillance system. While laboratory data were not avail-
able to designate “definite” imputability based on NHSN criteria, two of these severe reac-
tions were highly consistent with sepsis due to bacterial contamination of the donor unit and 
acute hemolytic reactions, respectively. The occurrence of these unreported severe transfu-
sion reactions is concerning, but suggests that implementation of targeted interventions to 
improve bedside monitoring of patient signs and symptoms around the time of transfusion 
and facilitate reporting of suspected reactions to the surveillance system, could effectively 
reduce transfusion-related morbidity and mortality in Namibia. Consistent with previous ob-
servations, we found a higher rate of acute transfusion reactions occurring among platelet 
transfusions, followed by PRBCs and FFP, respectively. [15] 
 Some studies, restricted to one or few hospitals, have described prevalence and rates of 
acute transfusion reactions elsewhere in sub-Saharan Africa, with some reporting regional, 
not facility-based, estimates. [22,27,28,32] Due to differences in methodology, these reports 
describe widely varying rates and percentages of transfusions resulting in acute transfusion 
reactions. [22,27,28,32] The transfusion reaction rate reported here is generally comparable 
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with another rate reported elsewhere in sub-Saharan Africa. [28] Compared to industrialized 
countries, the rates and percentages described here are higher. [16,17,33-36] While this may 
reflect safer transfusion practices in industrialized countries, some of the differences may 
be attributable to varying representativeness, [35] reporting practices, [36,37] classification 
schemes, [16,17] and disease definitions adopted by individual transfusion reaction surveil-
lance systems. [33] Furthermore, this study design may have resulted in higher percentages 
and rates than those described in other countries. Reviewing medical records for clinical evi-
dence of acute transfusion reactions as described in this study constitutes ‘active’ surveillance 
and may result in higher estimated rates and percentages of acute transfusion reactions than 
the ‘passive’ surveillance method used by the NAMBTS hemovigilance system, which relies on 
healthcare worker reporting. [38]
  The discrepancy between the reported and estimated percentages of acute transfusion re-
actions occurring in Windhoek may have two possible explanations: 1) A lack of transfusion 
reaction-related knowledge among healthcare workers or, 2) Infrastructure-related challeng-
es. Since the launch of the national transfusion reaction surveillance system in Namibia, ex-
tensive training and outreach activities have been conducted by NAMBTS. However, given 
frequent staff turnover and movement of healthcare workers within and between facilities, 
many individuals involved in ordering or performing transfusions may not have yet partici-
pated in these training activities, resulting in reduced awareness related to appropriate pa-
tient monitoring, and transfusion reaction recognition and reporting. As NAMBTS continues 
outreach and training activities and enhances awareness among healthcare workers, acute 
transfusion reaction reporting should improve. In neighboring South Africa, a steady increase 
in reporting has been observed as the blood service has increased education and awareness 
activities among healthcare workers. [39] Addressing infrastructure-related barriers to re-
porting will likely pose a continued challenge in Namibia and other parts of sub-Saharan Af-
rica. Limited telecommunication capacity, [40] challenges related to specimen transport [41] 
and few available transfusion medicine specialists [42] may preclude adequate reporting and 
investigation of acute transfusion reactions in these resource-limited settings. In Namibia, a 
national electronic medical record system is planned and once implemented, could be linked 
with NAMBTS to ease reporting challenges. While electronic systems may improve transfu-
sion reaction reporting, [36] similar systems may be difficult to implement in other more re-
source-limited settings of sub-Saharan Africa.
Targeted interventions to address non-infectious causes of adverse transfusion reactions may 
provide an additional safety benefit to transfusion recipients in Namibia and similar settings. 
Nearly one-third of the acute transfusion reactions identified through the chart review were 
febrile non-hemolytic reactions with five respiratory-related transfusion reactions and three 
allergic reactions. Leukoreduction with filtration has been previously demonstrated to reduce 
the incidence of febrile, non-hemolytic reactions in industrialized countries. [43] However, 
this procedure is not routinely performed by NAMBTS due to cost considerations (personal 
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communication R. Wilkinson, 7 April 2012).20 Furthermore, prevention of anaphylactic or other 
allergic acute transfusion reactions has been suggested by transfusing IgA-deficient plasma. 
[44] This intervention is unlikely to be feasible due to testing capacity or cost considerations 
in sub-Saharan Africa. Some interventions however, may be implemented at low or limited 
cost. Transfusion-associated circulatory overload may be prevented by diuretic therapy and 
slowing the transfusion rate for patients previously experiencing this reaction. [44] The oc-
currence of respiratory complications including transfusion-related acute lung injury may be 
prevented by preparing FFP solely from male or nulliparous female donors. [44] Given the 
relatively low use of FFP in Namibia, this intervention is unlikely to raise costs associated with 
component preparation or targeted donor recruitment. 
 A substantial burden of bacterial contamination of donor blood units has been reported 
in sub-Saharan Africa. [23] Consistent with this observation, our study detected at least one 
likely instance of sepsis due to bacterial contamination of the donor blood unit. These find-
ings suggest that implementation of targeted interventions to decrease bacterial contamina-
tion of donated blood units in sub-Saharan Africa may reduce transfusion-related morbidity 
and mortality. Many interventions, previously demonstrated to be effective in industrialized 
countries, could be implemented in the region at low or minimal cost. Some of these, in-
cluding deferral of donors with signs of illness or who have recently undergone medical or 
dental procedures and limitation of storage time prior to initiating transfusions, have already 
been instituted in Namibia. [35] Furthermore, NAMBTS has implemented diversion pouches 
to reduce bacterial entry into donor units. [45] An additional effective low-cost intervention 
which could be broadly implemented is a timed, double-swab disinfection protocol of the 
skin prior to collection, which is currently planned in Namibia in response to the findings of 
this study. [45] Consistent with observations in industrialized countries, our study also found 
high rates of transfusion reactions for platelets. [15] Given existing challenges with storage 
and transportation, other blood services in the region may consider the need for additional 
infrastructure improvements prior to implementation of platelet production. 
 This study is subject to the following limitations. Only transfusion events occurring in 
Windhoek were included in the study sample. The findings may not be generalizable to all of 
Namibia or to other countries in sub-Saharan Africa. Documentation in the medical records 
may have been incomplete and laboratory and radiographic data were frequently unavail-
able. This may have resulted in underestimation or misclassification of acute transfusion re-
actions detected. Several medical records were not located in two facilities. As a result, pa-
tient demographic information, blood component types and number of units, and clinical 
signs and symptoms related to transfusion events contained within these records are un-
known. Despite some statistical adjustments, non-response bias cannot be excluded. Likely 
due to the relatively small numbers of FFP and platelet units included in the study sample, the 
20  NAMBTS currently performs buffy coat depletion on PRBC units prior to storage.
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RSE for estimates of acute transfusion reactions per 1,000 units transfused for each of these 
component types exceeded 30%. While there is no set cutoff, estimates with RSE greater than 
30% may be statistically unreliable and should be interpreted with caution. [46] 
 While blood services have made substantial progress toward improving the safety and 
adequacy of blood supplies in many sub-Saharan African countries, [47] several challenges 
related to improving transfusion safety remain, especially to address adverse outcomes with 
non-infectious and infectious etiologies. These findings highlight an important gap in current 
investments in blood safety in sub-Saharan Africa, particularly in the area of patient safety 
during and following transfusions. Future studies in the region should reassess the burden 
of acute transfusion reactions after implementing targeted interventions. National health 
authorities and external donors should consider expanding current blood safety projects to 
emphasize transfusion safety and surveillance for adverse transfusion reactions, as well as 
the prevention of transfusion-transmissible infections. 
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